IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q3 2020 Holdings

Filed 2020-11-16 | 17 holdings | $25.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$22.5M523,41588.6%
Argenx SE(ARGX)SPONSORED ADR04016X101$2.0M7,5007.7%
Spdr SER TR S&P Biotech(XBI)PutUNIT78464A870$445.7K4,000,0001.8%
Ishares TR Russell 2000(IWM)PutETF UNIT464287655$254.6K1,700,0001.0%
Spero Therapeutics Inc(SPRO)COM84833T103$50.2K4,497,1420.2%
Blueprint Medicines Corp(2L9)COM09627Y109$35.8K385,7270.1%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$24.7K1,374,7760.1%
Uniqure NV(QURE)SHSN90064101$23.2K631,0600.1%
Anaptysbio Inc(ANAB)COM032724106$21.8K1,477,6520.1%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$16.2K1,018,3340.1%
Regenxbio Inc(RGNX)COM75901B107$14.1K510,7600.1%
Proqr Thrapeutics N VSHS EURON71542109$10.9K2,281,9660.0%
Pieris Pharmaceuticals IncCOM720795103$7.6K3,675,5300.0%
Magenta Therapeutics IncCOM55910K108$6.5K958,6180.0%
Galapagos NV(GLPG)SPON ADR36315X101$4.6K32,5340.0%
AC Immune SA(ACIU)SHSH00263105$2.3K463,5750.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$1.8K50,0000.0%